Join
Live feed
·
INSIDERFilingvia Quantisnow
Nuvectis Pharma Inc. logo

Director Kaplan Matthew L. bought $64,240 worth of shares (11,000 units at $5.84), increasing direct ownership by 10% to 124,760 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NVCT· Nuvectis Pharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NVCT (Nuvectis Pharma Inc.) and more on Quantisnow.